You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Daunorubicin

Showing 1 - 25 of 392
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Tumor, Acute Myeloid

Not yet recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • (no location specified)
Sep 29, 2022

Acute Lymphocytic Leukemia, Acute Myeloid Leukemia Trial in Fairway (Daunorubicin)

Completed
  • Acute Lymphocytic Leukemia
  • Acute Myeloid Leukemia
  • Daunorubicin
  • Fairway, Kansas
    University of Kansas Cancer Center - Clinical Research Center
Jan 12, 2022

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute

Recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +3 more
  • Gemtuzumab Ozogamicin
  • Liposome-encapsulated Daunorubicin-Cytarabine
  • Houston, Texas
    M D Anderson Cancer Center
Jun 2, 2021

Acute Myeloid Leukemia Trial in Baltimore, New York, Chapel Hill (Alvocidib, Cytarabine, Daunorubicin)

Completed
Has Results
  • Acute Myeloid Leukemia
  • Baltimore, Maryland
  • +2 more
Apr 4, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia, Chronic Myelomonocytic Leukemia Trial in Chapel

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Chapel Hill, North Carolina
  • +1 more
Aug 2, 2022

Acute Myeloid Leukemia Trial in Tianjin (Daunorubicin Cytarabine liposome for injection, Vyxeos?Daunorubicin Cytarabine liposome

Recruiting
  • Acute Myeloid Leukemia
  • Daunorubicin Cytarabine liposome for injection
  • Vyxeos、Daunorubicin Cytarabine liposome for injection
  • Tianjin, China
    Institute of Hematology and Hospital of Blood Disease, Chinese A
Jun 7, 2021

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia Arising

Not yet recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • (no location specified)
Sep 29, 2022

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Philadelphia (Palbociclib, Tazemetostat,

Not yet recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Philadelphia, Pennsylvania
    Thomas Jefferson University Hospital
Nov 16, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial (Azacitidine, Biospecimen Collection, Bone Marrow Aspiration)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • (no location specified)
Sep 29, 2022

Acute Myeloid Leukemia Trial (Azacitidine, Biospecimen Collection, Bone Marrow Aspirate)

Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
Sep 29, 2022

Acute Myeloid Leukemia Trial (Quizartinib, Treatment according to Physician's Choice, Standard of Care Chemotherapy)

Withdrawn
  • Acute Myeloid Leukemia
  • (no location specified)
May 18, 2022

Acute Myeloid Leukemia (AML) Trial in Tianjin (Donafenib)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Tianjin, Tianjin, China
    Institute of Hematology and Blood Disease Hospital
Jun 21, 2021

Acute Myeloid Leukemia, MDS Trial in Bronx (Venetoclax Oral Tablet, Daunorubicin, Cytarabine)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Venetoclax Oral Tablet
  • +2 more
  • Bronx, New York
    Montefiore Einstein Cancer Center
Jul 14, 2022

Acute Myeloid Leukemia Trial in United States (Cytarabine, Idarubicin, Daunorubicin)

Recruiting
  • Acute Myeloid Leukemia
  • Duarte, California
  • +4 more
Aug 3, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia

Completed
Has Results
  • Acute Myeloid Leukemia
  • +2 more
  • Laboratory Biomarker Analysis
  • Liposome-encapsulated Daunorubicin-Cytarabine
  • Houston, Texas
    M D Anderson Cancer Center
Jan 8, 2021

Recurrent Acute Myeloid Leukemia Trial in United States (Enasidenib Mesylate, Liposome-encapsulated Daunorubicin-Cytarabine)

Suspended
  • Recurrent Acute Myeloid Leukemia
  • Enasidenib Mesylate
  • Liposome-encapsulated Daunorubicin-Cytarabine
  • Los Angeles, California
  • +3 more
Oct 21, 2021

Newly Diagnosed Acute Myeloid Leukemia (AML) Trial in Chengdu (SKLB1028 Dose Escalation)

Recruiting
  • Newly Diagnosed Acute Myeloid Leukemia (AML)
  • SKLB1028 Dose Escalation
  • Chengdu, China
    West China Hospital of Sichuan University
Jun 30, 2022

MDS Trial in New Haven (CPX-351)

Withdrawn
  • MDS
  • New Haven, Connecticut
    Yale University; Smilow Cancer Center
Jan 6, 2022

Acute Myeloid Leukemia, Adult, AML, AML, Adult Trial in La Jolla (Fludarabine, Vyxeos)

Recruiting
  • Acute Myeloid Leukemia, Adult
  • +2 more
  • La Jolla, California
    UCSD Moores Cancer Center
Mar 30, 2021

Acute Myeloid Leukemia (AML) Trial in Germany, United States (cytarabine, daunorubicin HCl, midostaurin)

Completed
  • Acute Myeloid Leukemia (AML)
  • Los Angeles, California
  • +5 more
Dec 16, 2020

Leukemia, Myeloid, Acute Trial (Cytarabine, Venetoclax, CPX-351)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • (no location specified)
Nov 25, 2022

Acute Lymphoblastic Leukemia Trial in Memphis (Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia L-asparaginase, Doxorubicin, Cyclophosphamide, Cytarabine, Thioguanine
  • Clofarabine, Methotrexate, Mercaptopurine, Dexamethasone, Etoposide, Dasatinib
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jul 26, 2022

T-cell Lymphoblastic Lymphoma Trial in Shanghai, Chengdu (Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine,

Not yet recruiting
  • T-cell Lymphoblastic Lymphoma
  • Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine, methotrexate, Dexamethasone, Doxorubicin
  • Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine, methotrexate, Dexamethasone, Doxorubicin, Vindesine, Etoposide, Ifosfamide
  • Shanghai, Shanghai, China
  • +1 more
Dec 27, 2022

Acute Myeloid Leukemia Trial in Miami (CPX-351, Midostaurin, Busulfan)

Recruiting
  • Acute Myeloid Leukemia
  • Miami, Florida
    Miami Cancer Institute at Baptist Health of South Florida
Jul 27, 2022

Myeloid Tumor Trial in Memphis (CPX-351, MHA)

Not yet recruiting
  • Myeloid Neoplasm
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Dec 9, 2022